ArticleFrontiers in medicine2026
Case Report: Adult fibrinous bronchitis associated with lymphatic reflux: a probable diagnosis based on convergent evidence.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fibrinous bronchitis, also known as plastic bronchitis, is a rare airway disorder characterized by branching bronchial casts that replicate the architecture of the bronchial tree. Adult cases are uncommon and frequently misdiagnosed because clinical manifestations and imaging findings are nonspecific. Diagnosis is particularly challenging in the absence of bronchoscopic or histologic confirmation of casts. Case presentation: We present a 52-year-old man with a 2-year history of recurrent cough and expectoration of branching mucoid casts. Serial chest imaging showed fluctuating infiltrates without bronchiectasis. Bronchoscopy did not identify casts, presumably because the procedure was performed outside the active expectoration phase. Microbiologic findings were intermittent and not associated with sustained response to antimicrobial therapy. Transbronchial biopsy demonstrated chronic mucosal inflammation with fibrinous exudation, consistent with a fibrin-predominant airway process. Radionuclide lymphoscintigraphy and direct lymphangiography showed mediastinal lymphatic dilatation and pulmonary lymphatic reflux. Based on a convergent evidence framework, a probable diagnosis of fibrinous bronchitis was made. This was based on reproducible cast morphology, supported by indirect histopathologic findings, objective lymphatic abnormalities, and the mismatch between symptoms and treatment response. The patient remained asymptomatic with no recurrence at 8 months following targeted lymphatic embolization. Discussion: This case highlights the diagnostic challenge of adult fibrinous bronchitis in the absence of direct bronchoscopic or histologic confirmation of casts. It suggests that reproducible morphologic features, when interpreted alongside supportive histologic findings and mechanism-oriented imaging, can provide a practical basis for diagnosis. Recognition of symptom-treatment discordance may further prompt reconsideration of non-infectious mechanisms, including lymphatic dysfunction. Conclusion: In the absence of direct confirmation, a probable diagnosis of fibrinous bronchitis can be supported by converging evidence. Reproducible morphologic patterns, integrated with mechanism-oriented imaging, offer a practical basis for diagnosis and management in rare airway diseases and may facilitate earlier recognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.